Total Payments
$9,288
2024 Payments
$1,862
Companies
35
Transactions
444
Medicare Patients
2,485
Medicare Billing
$404,878
Payment Breakdown by Category
Food & Beverage$9,257 (99.7%)
Education$30.51 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,257 | 441 | 99.7% |
| Education | $30.51 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,055 | 127 | $0 (2024) |
| Lilly USA, LLC | $943.52 | 45 | $0 (2024) |
| PFIZER INC. | $886.44 | 39 | $0 (2024) |
| Novo Nordisk Inc | $863.52 | 42 | $0 (2024) |
| Merck Sharp & Dohme LLC | $818.19 | 42 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $776.97 | 37 | $0 (2024) |
| Amgen Inc. | $695.83 | 27 | $0 (2024) |
| Corcept Therapeutics | $333.39 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $322.42 | 8 | $0 (2019) |
| Boston Scientific Corporation | $266.84 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,862 | 87 | Novartis Pharmaceuticals Corporation ($439.97) |
| 2023 | $1,328 | 65 | Novartis Pharmaceuticals Corporation ($354.22) |
| 2022 | $1,520 | 76 | Novartis Pharmaceuticals Corporation ($373.01) |
| 2021 | $1,122 | 70 | Novartis Pharmaceuticals Corporation ($196.40) |
| 2020 | $736.79 | 38 | Lilly USA, LLC ($203.17) |
| 2019 | $862.45 | 38 | Novartis Pharmaceuticals Corporation ($163.26) |
| 2018 | $836.07 | 23 | PFIZER INC. ($280.29) |
| 2017 | $1,021 | 47 | Novartis Pharmaceuticals Corporation ($348.45) |
All Payment Transactions
444 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiovascular Diseases | ||||||
| 12/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Obesity | ||||||
| 11/02/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: OSTEOARTHRITIS | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Corcept Therapeutics | Korlym (Drug) | Education | In-kind items and services | $11.29 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: DIABETES | ||||||
| 08/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: Cardiology | ||||||
| 08/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 643 | 1,070 | $283,036 | $98,748 |
| 2022 | 13 | 608 | 931 | $232,222 | $88,051 |
| 2021 | 14 | 713 | 1,145 | $370,059 | $120,377 |
| 2020 | 14 | 521 | 879 | $284,253 | $97,702 |
Total Patients
2,485
Total Services
4,025
Medicare Billing
$404,878
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 391 | $47,925 | $33,476 | 69.9% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 97 | 141 | $42,250 | $13,941 | 33.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 62 | 72 | $36,000 | $11,048 | 30.7% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 49 | 77 | $46,200 | $9,404 | 20.4% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 88 | 116 | $34,800 | $7,666 | 22.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 18 | 18 | $19,000 | $6,456 | 34.0% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 41 | 51 | $17,900 | $5,507 | 30.8% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 52 | 62 | $9,920 | $4,315 | 43.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 11 | 12 | $6,000 | $1,904 | 31.7% |
| 93701 | Measurement of heart blood flow and respiration | Office | 2023 | 55 | 78 | $7,800 | $1,750 | 22.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 16 | 17 | $2,666 | $1,373 | 51.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 16 | 17 | $6,375 | $985.35 | 15.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 18 | 18 | $6,200 | $921.78 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 323 | $37,145 | $27,724 | 74.6% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 92 | 112 | $33,600 | $12,000 | 35.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 59 | 64 | $32,000 | $10,729 | 33.5% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 88 | 116 | $18,560 | $8,774 | 47.3% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 86 | 118 | $35,400 | $8,488 | 24.0% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 34 | 42 | $25,200 | $5,340 | 21.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 13 | 13 | $13,000 | $5,121 | 39.4% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2022 | 31 | 32 | $11,200 | $3,603 | 32.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 13 | 13 | $6,500 | $2,208 | 34.0% |
| 93701 | Measurement of heart blood flow and respiration | Office | 2022 | 39 | 53 | $5,300 | $1,241 | 23.4% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2022 | 16 | 21 | $7,875 | $1,174 | 14.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 11 | 11 | $1,892 | $960.78 | 50.8% |
About Dr. Michael Milbourne, MD
Dr. Michael Milbourne, MD is a Internal Medicine healthcare provider based in Glenside, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255399366.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Milbourne, MD has received a total of $9,288 in payments from pharmaceutical and medical device companies, with $1,862 received in 2024. These payments were reported across 444 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($9,257).
As a Medicare-enrolled provider, Milbourne has provided services to 2,485 Medicare beneficiaries, totaling 4,025 services with total Medicare billing of $404,878. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nuclear Cardiology, Cardiovascular Disease
- Location Glenside, PA
- Active Since 05/01/2006
- Last Updated 03/23/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1255399366
Products in Payments
- ENTRESTO (Drug) $1,795
- VERQUVO (Drug) $818.19
- ELIQUIS (Drug) $683.66
- JARDIANCE (Drug) $672.15
- Repatha (Biological) $536.02
- Ozempic (Drug) $466.27
- MOUNJARO (Drug) $413.56
- TRULICITY (Drug) $396.11
- Korlym (Drug) $333.39
- LEQVIO (Drug) $259.89
- XARELTO (Drug) $169.59
- Corlanor (Drug) $159.81
- INVOKANA (Drug) $152.83
- Tresiba (Drug) $152.75
- WATCHMAN DEVICE (Device) $148.32
- Creon (Drug) $138.55
- Adempas (Drug) $134.08
- Peripheral Orbital Atherectomy System (Device) $107.71
- WATCHMAN (Device) $105.16
- Livalo (Drug) $101.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.